Jing Gao's profile

Jing Gao

Research Associate

Protelight

I'm working on

2 years ago

Antimicrobial Peptide for the Treatment of Vaginal Infections

About

Peptide drug PL-18 has completed Phase I clinical studies on Colpomycosis, Bacterial Vaginosis, and mixed Vaginitis in Australia and China. An ongoing phase II trial in China aims to clarify the efficacy and safety in patient populations with Vulvovaginal Candidiasis (VVC).

Partnering listings

Learn more

Protelight

Antimicrobial peptide PL-18 for treating vaginal infections

ProteLight Biopharma's PL-18 antimicrobial peptide offers a novel treatment for Vulvovaginal Candidiasis (VVC) and Recurrent VVC, with broad-spectrum activity and reduced resistance risk. Phase Ib trials completed; seeki...

TechnologyIn developmentCompany

Jing Gao

Research Associate

Protelight

Work experience

Protelight

Research Associate

2009 - Present

Protelight Pharma

Research Associate

2009 - Present

Top industry applications